Screening of Immunosuppressive Factors for Biomarkers of Breast Cancer Malignancy Phenotypes and Subtype-Specific Targeted Therapy

PeerJ - United States
doi 10.7717/peerj.7197
Full Text
Abstract

Available in full text

Date
Authors
Publisher

PeerJ

Related search

Targeted Therapy for Breast Cancer Prevention

Frontiers in Oncology
Cancer ResearchOncology
2013English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2010English

CXCR4-targeted Therapy in Breast Cancer

The Lancet Oncology
Oncology
2018English

Impact of Race and Tumor Subtype on Second Malignancy Risk in Women With Breast Cancer

SpringerPlus
Multidisciplinary
2016English

Biocompatible ELR-Based Polyplexes Coated With MUC1 Specific Aptamers and Targeted for Breast Cancer Gene Therapy

English

Biomarkers and Response to Therapy in Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2009English

Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

Unexpected Features of Breast Cancer Subtype

World Journal of Surgical Oncology
SurgeryOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy